Views & Analysis Considerations for Mobile Health Technology Developers: Part... In Part 1 of this series, general wellness devices and mobile me
Views & Analysis Considerations for Mobile Health Technology Developers: Part... In Part 1 of this series, general wellness devices and mobile medical applications (MMAs) will be considered. Part 2 of this series will be devoted to clinical decision support (C
Views & Analysis The real conspiracy in the pharma industry Paul Tunnah on how pharma industry workers can negatively affect patients without even realising it.
Partner Content Partner Content PLIVA explores impact of EU Guidelines on evaluation of modi... PLIVA explores EU Guidelines for modified release drugs
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
